1. "Ross Levine"
  2. "Kamal Menghrajani"
Formats
  1. Meeting Abstract (17)
  2. Journal Article (6)
  3. Research Letter (1)
Groups
  1. Adult Leukemia (24)
  2. Center for Hematologic Malignancies (24)
  3. Department of Medicine (24)
  4. Executive Committee, Center for Hematologic Malignancies (24)
  5. GSK Faculty (24)
  6. Hematologic Malignancies, Division of (24)

More Groups

People
  1. Kamal Menghrajani (24)
  2. Ross Levine (24)
  3. Christopher Famulare (15)
  4. Jacob Glass (14)
  5. Martin Tallman (11)
  6. Mikhail Roshal (11)

More People

Years
  1. 2024 (1)
  2. 2023 (5)
  3. 2022 (1)
  4. 2021 (4)
  5. 2020 (6)
  6. 2019 (2)

More Years

Publications
  1. Blood (15)
  2. Blood Advances (3)
  3. American Journal of Hematology (2)
  4. Clinical Lymphoma, Myeloma and Leukemia (1)
  5. Haematologica (1)
  6. Laboratory Investigation (1)

More Publications

Publishers
  1. American Society of Hematology (18)
  2. John Wiley & Sons, Inc. (2)
  3. Nature Publishing Group (2)
  4. Elsevier Inc. (1)
  5. Ferrata Storti Foundation (1)

Results (24)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • High-risk and silent clonal hematopoietic genotypes in patients with nonhematologic cancer
    Journal Article

    Stonestrom, A. J.; Menghrajani, K. N.; Devlin, S. M.; Franch-Expósito, S.; Ptashkin, R. N.; Patel, S. Y.; Spitzer, B.; Wu, X.; Jee, J.; Vela, P. S.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • Precision lineage deconvolution in mixed phenotype acute leukemia using CITE-seq derived hematopoietic stages identifies lineage dynamics associated with treatment response
    Meeting Abstract

    Dilip, D.; Galera, P.; Nemirovsky, D.; Lallo, M.; Menghrajani, K.; Derkach, A.; Levine, R. L.; Koche, R.; Xiao, W.; Glass, J.
    Blood (2023)

    Fulltext@MSK | Save
  • Genomic profiles and associated survival prognosticators in Black patients with acute myeloid leukemia
    Meeting Abstract

    Stiff, A.; Nicolet, D.; Fornerod, M.; Kelly, B.; Miller, K.; Mrózek, K.; Boateng, I.; Kain, B. N.; Garfinkle, E.; Hu, E. Y.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Deconvoluting clonal and cellular architecture in IDH-mutant acute myeloid leukemia
    Meeting Abstract

    Sirenko, M.; Lee, S.; Sun, Z.; Chaligne, R.; Asimomitis, G.; Brierley, C. K.; Bernard, E.; Cai, S. F.; Myers, R. M.; Nadorp, B.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • MPN transformation is characterized by heterogeneous shifts in lineage character
    Meeting Abstract

    Dilip, D.; Menghrajani, K.; Glass, J.; Rampal, R. K.; Famulare, C.; Sirenko, M.; Levine, R. L.; Koche, R.
    Blood (2023)

    Fulltext@MSK | Save
  • Molecular predictors of immunophenotypic measurable residual disease clearance in acute myeloid leukemia
    Journal Article

    Stahl, M.; Derkach, A.; Farnoud, N.; Bewersdorf, J. P.; Robinson, T.; Famulare, C.; Cho, C.; Devlin, S.; Menghrajani, K.; Patel, M. A.; more...
    American Journal of Hematology (2023)

    Fulltext@MSK | Save
  • Quantitative cytogenetic analysis with karyoParser allows for more precise identification of disease biology, clonal evolution, and etiology of relapse in acute myeloid leukemia
    Meeting Abstract

    Dilip, D.; Derkach, A.; Menghrajani, K.; Goldberg, A. D.; May, H.; Klimek, V. M.; Galera, P. K.; Xiao, W.; Zhang, Y.; Elemento, O.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Single cell ATAC lineage deconvolution reveals overlapping subclones in epigenetically distinct AML samples
    Meeting Abstract

    Dilip, D.; Koche, R.; Menghrajani, K.; Melnick, A.; Elemento, O.; Levine, R. L.; Glass, J. L.
    Blood (2021)

    Fulltext@MSK | Save
  • The prognosis and durable clearance of RAS mutations in patients with acute myeloid leukemia receiving induction chemotherapy
    Research Letter

    Ball, B. J.; Hsu, M.; Devlin, S. M.; Arcila, M.; Roshal, M.; Zhang, Y.; Famulare, C. A.; Goldberg, A. D.; Cai, S. F.; Dunbar, A.; more...
    American Journal of Hematology (2021)

    Fulltext@MSK | Save
  • Clinical and molecular predictors of response and survival following venetoclax therapy in relapsed/refractory AML
    Journal Article

    Stahl, M.; Menghrajani, K.; Derkach, A.; Chan, A.; Xiao, W.; Glass, J.; King, A. C.; Daniyan, A. F.; Famulare, C.; Cuello, B. M.; more...
    Blood Advances (2021)

    Fulltext@MSK | Save